The DCIS Score provides clinically relevant information about personal risk that can guide patient discussions and facilitate shared decision making.
Oncology Vol 28 No 5_Suppl_2
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Ruxolitinib Tablets for Hematologic Malignancies
2
FDA Permits Expanded Daraxonrasib Access in Previously Treated Metastatic PDAC
3
Unraveling Daraxonrasib’s Breakthrough in Metastatic Pancreatic Cancer
4
Precision Medicine and the “Slow Death” of Transplant in Lymphoma
5